Intuitive Surgical’s second quarter results were marked by strong procedure growth and robust capital equipment placements, ...

Intuitive Surgical, Inc. (ISRG) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Intuitive Surgical hasn't lost its edge, but it is an overvalued stock. Investors may want to prepare for a five-year period ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks that Jim Cramer weighed in on. In response to a caller’s query ...

We recently published 9 Stocks Jim Cramer Discussed As He Commented On Big Tech. Intuitive Surgical, Inc. (NASDAQ:ISRG) is ...

Surgical Instrument Service Co. is asking the Ninth Circuit to revive its claims that Intuitive Surgical Inc. has a ...

Intuitive Surgical routinely trades at a premium to the broader market, with an average price-to-earnings (P/E) ratio of 61 over the past decade. However, the price got a bit excessive late last year.

Intuitive Surgical reports second-quarter revenue of $2.44 billion, beating analyst estimates of $2.35 billion, according to ...

Intuitive Surgical launched its first commercial system in 1999 and after winning Food and Drug Administration approval in 2000, it sold 28 da Vinci systems, generating $26.6 million in sales.

Intuitive Surgical’s operating margin of 31.6% over the last twelve months is much higher than 16.1% for Stryker. This compares with 30.7% and 18.2% figures in 2019, before the pandemic ...

But Intuitive Surgical is actually on track to achieve an even better performance in 2018 than it did last year. The company should post revenue of at least $3.6 billion -- 16% higher year over year.

Intuitive Surgical currently trades at a price-to-earnings (P/E) ratio of 75. Meanwhile, analysts estimate the company will grow earnings by an average of just over 13.8% annually over the long term.